Q1 2024 Investor Presentation
If you’re interested in learning more about ALRT you can view or download our latest investor presentation here, you can also find all of the company’s press releases below. Please feel free to contact IR for all other inquiries.
Get our investor package
Please enter your information to receive our corporate presentation and an introductory message from our IR department.
Latest Releases
Stock Information
Trading on OTCQB since 1999, ALRT has demonstrated a solid opportunity to leverage the rapid growth of the biotechnology industry.
Company Profile
ALR Technologies is a data management company that developed the ALRT Diabetes Solution, a comprehensive approach to diabetes care that includes: an FDA-cleared and HIPAA compliant diabetes management system that collects data directly from blood glucose meters and continuous glucose monitoring devices; a patent pending Predictive A1C algorithm to track treatment success between lab reports and an FDA-cleared Insulin Dosing Adjustment program. Currently, the Company is focused on diabetes and will expand its services to cover other chronic diseases anchored on verifiable data.
In addition, the animal health division has identified an unmet need in diabetes care and has developed a solution to assist veterinarians in determining the effectiveness of insulin and helping to identify the appropriate dose and frequency of administration for companion animals. Thus, delivering the same optimization of diabetic drug therapies to pets as to humans.